Subscribe to Our Newsletter Join our newsletter to stay up to date on dangerous drugs and devices, keep up on lawsuit and settlement news, learn about FDA recalls, and more. Sign Up NowConnect with Drugwatch on Twitter
The spokesperson added that cutting expenses is one of Pfizer'sfive priorities for the year, along with maximizing the performance of new products, innovating its drug pipeline, growing its oncology business with itsacquisition of cancer drugmaker Seagen, and allocating capital to increase its dividen...
Pfizer agrees with some of the points Starboard raised, but has "vastly different views on many others," Bourla said. For example, Starboard challenged Pfizer's capital deployment for business development. But Pfizer believes its deals will bring significant shareholder returns, Bourla said. Bourla ...
ELIQUIS® (apixaban)3 $6,440 million PREVNAR® Family4 $4,753 million IBRANCE® (palbociclib) $3,321 million VYNDAQEL® Family5 $1,703 million XELJANZ® (tofacitinib) $1,279 million PAXLOVID® (nirmatrelvir tablets and ritonavir tablets) ...
So, Chris, as you noted, BMS led the discussions with CMS on Eliquis maximum pure price because they are the NDA holder, and they shared their perspective on that process during theirearnings calllast week. Honestly, we don't have much to add to what they said. We share their view that...
Alternative Names: BMS-562247; BMS-562247-01; Eliquis Latest Information Update: 05 Nov 2023 Price : €55 * Buy Profile Note: Adis is an information provider. We do not sell or distribute actual drugs. Final gross price and currency may vary according to local VAT and billing addr...
Next, we have Tim Anderson with Wolfe Research. Tim Anderson--Wolfe Research -- Analyst Thank you. Maybe for Aamir. So Eliquis is the biggest drug on the initial list of 10 drugs for IRA. CMS has until February 1st to provide you the initial proposed negotiated price so that's two days...
Bristol-Myers Squibb-Pfizer Alliance welcome decision by US Court of Appeals for the Federal Circuit upholding Eliquis patents
- REVENUES THIRD-QUARTER 2023 and 2022 - (UNAUDITED) (MILLIONS) TOTAL REVENUES GLOBAL BIOPHARMACEUTICALS BUSINESS (BIOPHARMA)(b) Primary Care Comirnaty direct sales and alliance revenues(c) Eliquis alliance revenues and direct sales Prevnar family(d) Paxlovid Nurtec ODT/Vydura Abrysvo Premarin ...
The scoop:Approved to help improve glycemic control in adults with Type 2 diabetes, the 20 mg tablets of bexagliflozin are designed to be taken once a day alongside diet and exercise. The SGLT2 inhibitor helps lower blood sugar by preventing the kidneys from reabsorbing sugar creat...